J. Goldman & CO LP Krystal Biotech, Inc. Transaction History

J. Goldman & CO LP

$3.21 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$108.01 - $179.35 $1.68 Million - $2.79 Million	15,555 Added 287.63%	20,963 $3.73 Million
Q4 2023 Feb 14, 2024	SELL	$96.0 - $128.29 $2.86 Million - $3.82 Million	-29,805 Reduced 84.64%	5,408 $670,000
Q3 2023 Nov 14, 2023	BUY	$108.51 - $130.22 $3.24 Million - $3.89 Million	29,864 Added 558.31%	35,213 $4.08 Million
Q2 2023 Aug 14, 2023	BUY	$78.48 - $130.32 $207,972 - $345,348	2,650 Added 98.18%	5,349 $627,000
Q1 2023 May 15, 2023	SELL	$72.39 - $84.27 $1.2 Million - $1.4 Million	-16,620 Reduced 86.03%	2,699 $216,000
Q4 2022 Feb 14, 2023	BUY	$63.14 - $79.9 $593,010 - $750,420	9,392 Added 94.61%	19,319 $1.53 Million
Q3 2022 Nov 14, 2022	SELL	$64.85 - $82.4 $263,485 - $334,791	-4,063 Reduced 29.04%	9,927 $692,000
Q2 2022 Aug 15, 2022	SELL	$48.93 - $73.47 $874,330 - $1.31 Million	-17,869 Reduced 56.09%	13,990 $919,000
Q1 2022 May 16, 2022	BUY	$51.99 - $72.11 $1.66 Million - $2.3 Million	31,859 New	31,859 $2.12 Million
Q4 2021 Feb 14, 2022	SELL	$39.81 - $88.24 $250,803 - $555,912	-6,300 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$52.01 - $71.77 $241,898 - $333,802	-4,651 Reduced 42.47%	6,300 $329,000
Q2 2021 Aug 16, 2021	BUY	$62.14 - $81.82 $4,722 - $6,218	76 Added 0.7%	10,951 $745,000
Q1 2021 May 17, 2021	SELL	$59.42 - $85.46 $329,365 - $473,704	-5,543 Reduced 33.76%	10,875 $838,000
Q4 2020 Feb 16, 2021	SELL	$40.64 - $61.38 $701,202 - $1.06 Million	-17,254 Reduced 51.24%	16,418 $985,000
Q3 2020 Nov 16, 2020	SELL	$37.76 - $48.49 $435,372 - $559,089	-11,530 Reduced 25.51%	33,672 $1.45 Million
Q2 2020 Aug 14, 2020	BUY	$37.03 - $60.0 $1.67 Million - $2.71 Million	45,202 New	45,202 $1.87 Million

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

Black Rock Inc. New York, NY

3.95M
Shares

$752 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

2.85M
Shares

$543 Million
0.01% of portfolio
Avoro Capital Advisors LLC New York, NY

2.62M
Shares

$499 Million
7.18% of portfolio
State Street Corp Boston, MA

1.45M
Shares

$277 Million
0.01% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

988K
Shares

$188 Million
9.67% of portfolio

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.89B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Account